Company Overview - Waters (WAT) is expected to report a year-over-year increase in earnings, with a projected EPS of $2.22, reflecting a change of +0.5% [3] - Revenues are anticipated to reach $654.63 million, marking a 2.8% increase from the previous year [3] Earnings Expectations - The consensus EPS estimate has been revised down by 0.22% over the last 30 days, indicating a reassessment by analysts [4] - The Zacks Earnings ESP for Waters is +0.20%, suggesting a likelihood of beating the consensus EPS estimate [11] Historical Performance - In the last reported quarter, Waters exceeded the expected EPS of $4.02 by delivering $4.10, resulting in a surprise of +1.99% [12] - Over the past four quarters, Waters has consistently beaten consensus EPS estimates [13] Industry Context - Idexx Laboratories (IDXX), a peer in the Zacks Medical - Instruments industry, is expected to report an EPS of $2.92, reflecting a year-over-year change of +3.9% [17] - Idexx's revenues are projected to be $1.02 billion, up 5.4% from the previous year [17] - The consensus EPS estimate for Idexx has been revised down by 0.4% in the last 30 days, with an Earnings ESP of -2.62%, indicating uncertainty in beating the consensus [18]
Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth